Neural and Molecular Mechanisms of Emotional Dysfunction after Sepsis

脓毒症后情绪功能障碍的神经和分子机制

基本信息

项目摘要

Project Summary/Abstract This proposal describes a four-year career development plan designed to lead the PI to a career as an independent clinician scientist studying the mechanisms of emotional vulnerability after severe medical illness. More than one third of critical illness survivors suffer long term from depression, anxiety, or post-traumatic stress disorder. Animal research on this topic is scarce, but is necessary in order to better understand the mechanisms of vulnerability and to identify targets for intervention. The long-term goal of this research is to identify the molecular mechanisms and neural circuitry behind emotional vulnerability after severe medical illness, and to translate this knowledge into effective strategies for the prevention and treatment of psychiatric disorders in critical illness survivors. Preliminary studies using a murine sepsis model, cecal ligation and puncture (CLP), showed increased anxiety-like behavior in CLP survivor mice, and in situ hybridization studies suggested a possible role for the ventral hippocampus. In the first Specific Aim, the candidate will investigate the role of the ventral hippocampus in anxiety-like behavior after CLP by examining the activity of ventral CA1 pyramidal cells after CLP using in vivo calcium imaging, and determining the effect of optogenetic activation of the ventral hippocampus on anxiety-like behavior. Studies of patients after traumatic experiences including critical illness have suggested that elevated circulating glucocorticoids during trauma may protect against post-traumatic stress symptoms in survivors. In the second Specific Aim, the candidate will investigate whether glucocorticoid treatment during the illness period can protect against negative emotional behavior in CLP survivors, and use RNA-seq to identify candidate genes that could mediate the effects of CLP and glucocorticoids on ventral hippocampal function and emotional behavior. The applicant holds M.D. and Ph.D. degrees and has completed clinical specialty training in Internal Medicine and Endocrinology. She has previous experience in behavioral endocrinology research using mouse models. This application includes a career development plan designed to update her scientific skills in techniques for investigating the neural circuits of behavior in awake, freely behaving animals, and in the design and analysis of large-scale gene expression data. The training will include didactic training, conferences and lab meetings, hands-on apprenticeship, and the communication of research findings through publications and presentation at national meetings. The mentorship team includes members of multiple departments/divisions and multiple institutions, in order to support this inherently interdisciplinary project. The mentors are able to provide a research environment with adequate resources to complete the proposed project.
项目概要/摘要 该提案描述了一个为期四年的职业发展计划,旨在引导 PI 成为一名 独立临床科学家研究严重疾病后情绪脆弱的机制。 超过三分之一的危重病幸存者长期患有抑郁、焦虑或创伤后症状 应激障碍。关于这一主题的动物研究很少,但为了更好地理解这一主题是必要的 脆弱性机制并确定干预目标。这项研究的长期目标是 确定严重医疗后情绪脆弱性背后的分子机制和神经回路 疾病,并将这些知识转化为预防和治疗精神疾病的有效策略 危重疾病幸存者的疾病。 使用鼠败血症模型、盲肠结扎和穿刺(CLP)的初步研究表明, CLP 幸存者小鼠的焦虑样行为,原位杂交研究表明, 腹侧海马体。在第一个特定目标中,考生将研究腹侧的作用 通过检查 CLP 后腹侧 CA1 锥体细胞的活性来观察 CLP 后海马的焦虑样行为 CLP 使用体内钙成像,并确定腹侧光遗传学激活的效果 海马体对焦虑样行为的影响。 对经历过包括危重病在内的创伤经历的患者的研究表明, 创伤期间循环的糖皮质激素可以预防幸存者的创伤后应激症状。在 第二个具体目标,考生将调查患病期间是否接受糖皮质激素治疗 期可以预防 CLP 幸存者的负面情绪行为,并使用 RNA-seq 来识别 介导CLP和糖皮质激素对腹侧海马功能影响的候选基因 和情绪行为。 申请人拥有医学博士和博士学位。学位并完成了内科临床专业培训 医学和内分泌学。她之前有使用小鼠进行行为内分泌学研究的经验 模型。该应用程序包括一个职业发展计划,旨在更新她的科学技能 研究清醒、自由行为动物的行为神经回路的技术,以及设计 以及大规模基因表达数据的分析。培训将包括教学培训、会议和 实验室会议、实践学徒以及通过出版物和研究成果的交流 在全国会议上的演讲。导师团队包括多个部门/部门的成员 和多个机构,以支持这个本质上跨学科的项目。导师们能够 提供具有充足资源的研究环境来完成拟议项目。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Joanna Louise Spencer-Segal其他文献

Joanna Louise Spencer-Segal的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Joanna Louise Spencer-Segal', 18)}}的其他基金

Neural and Molecular Mechanisms of Emotional Dysfunction after Sepsis
脓毒症后情绪功能障碍的神经和分子机制
  • 批准号:
    10507142
  • 财政年份:
    2022
  • 资助金额:
    $ 19.66万
  • 项目类别:
Estrogen Signaling and Synaptogenesis in Hippocampus: The Role of BDNF
海马雌激素信号传导和突触发生:BDNF 的作用
  • 批准号:
    7502656
  • 财政年份:
    2007
  • 资助金额:
    $ 19.66万
  • 项目类别:
Estrogen Signaling and Synaptogenesis in Hippocampus: The Role of BDNF
海马雌激素信号传导和突触发生:BDNF 的作用
  • 批准号:
    7407057
  • 财政年份:
    2007
  • 资助金额:
    $ 19.66万
  • 项目类别:
Estrogen Signaling and Synaptogenesis in Hippocampus: The Role of BDNF
海马雌激素信号传导和突触发生:BDNF 的作用
  • 批准号:
    7668618
  • 财政年份:
    2007
  • 资助金额:
    $ 19.66万
  • 项目类别:

相似国自然基金

下丘脑室旁核促肾上腺皮质激素释放激素神经元调控奖赏偏好行为的机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
INSM1在静默性促肾上腺皮质激素细胞腺瘤发生发展中的调控机制及潜在靶向治疗研究
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    55 万元
  • 项目类别:
    面上项目
促肾上腺皮质激素释放因子通过CRFR1-cAMP-SphK1通路介导肥大细胞脱颗粒参与胰腺癌痛外周敏化
  • 批准号:
    82171232
  • 批准年份:
    2021
  • 资助金额:
    54 万元
  • 项目类别:
    面上项目
催产素参与双相障碍发病机制的研究:聚焦于促肾上腺皮质激素释放激素与催产素之间的平衡紊乱
  • 批准号:
    81971268
  • 批准年份:
    2019
  • 资助金额:
    55 万元
  • 项目类别:
    面上项目

相似海外基金

Cellular and molecular mechanisms of alveolar repair
肺泡修复的细胞和分子机制
  • 批准号:
    10750085
  • 财政年份:
    2023
  • 资助金额:
    $ 19.66万
  • 项目类别:
Individualizing Steroid Use in Pneumonia
肺炎中类固醇的个体化使用
  • 批准号:
    10643595
  • 财政年份:
    2023
  • 资助金额:
    $ 19.66万
  • 项目类别:
Profiling the immune response to convalescent plasma therapy during severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection
分析严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2) 感染期间恢复期血浆治疗的免疫反应
  • 批准号:
    10609455
  • 财政年份:
    2022
  • 资助金额:
    $ 19.66万
  • 项目类别:
SCD-PICC Therapy for Respiratory Insufficiency associated with COVID-19 in non-ICU settings
SCD-PICC 治疗非 ICU 中与 COVID-19 相关的呼吸功能不全
  • 批准号:
    10481579
  • 财政年份:
    2022
  • 资助金额:
    $ 19.66万
  • 项目类别:
Profiling the immune response to convalescent plasma therapy during severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection
分析严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2) 感染期间恢复期血浆治疗的免疫反应
  • 批准号:
    10373738
  • 财政年份:
    2022
  • 资助金额:
    $ 19.66万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了